VP, General Counsel & Corporate Secretary John Felitti joined Transgene in 2016 as General Counsel & Corporate Secretary. Before joining Transgene, he was Associate Vice President, Corporate Law, Finance & Securities Law at Sanofi and previously held other positions in the Sanofi and the Aventis legal departments. From 1996 to 2003, he was an associate… Continue reading John FELITTI
Category: tools-profils-members
James Wentworth, PhD
VP, Chief Business Officer James Wentworth, PhD, joined Transgene in 2024. Dr. Wentworth is responsible for developing, leading, and implementing Transgene’s business, corporate development and partnering strategies. He has over 15 years of experience working in the pharma and biotech industry. James was Director, Business Development and Strategy at Adaptimmune, a NASDAQ-listed biotechnology company focused… Continue reading James Wentworth, PhD
Lucie Larguier
VP, Chief Financial Officer (CFO) Lucie is appointed on March 27 as Chief Financial Officer, responsible for all aspects of the Company’s financial strategy, management and operations to ensure efficient delivery of Transgene’s innovative immunotherapy pipeline. Since 2016, Lucie has served as Director Corporate Communications and Investor Relations, reporting to the CEO and joins the… Continue reading Lucie Larguier
Christophe ANCEL
VP, Pharmaceutical Operations & Qualified Pharmacist Christophe Ancel joined Transgene in 2008, first as Head of Quality Assurance and then as Vice President, Operational Quality. Prior to that, he was a consultant for several international pharmaceutical groups. From 2001 to 2005, he was Head of Quality, Assistant Pharmacist and Interim Responsible Pharmacist for the… Continue reading Christophe ANCEL
Hedi Ben Brahim
Director Hedi Ben Brahim has been Chairman and CEO, and CEO of Transgene from 2021 to 2023. Hedi Ben Brahim joined the Company from Institut Mérieux where he was Vice-President for Immunotherapy since 2018. In this role, he was the Chairman of ABL Inc., a contract research & development, and contract biomanufacturing organization (CRO/CMO).… Continue reading Hedi Ben Brahim